These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7900945)

  • 1. The p185erbB2 protein is localized on cell organelles involved in cell motility.
    De Potter CR; Quatacker J
    Clin Exp Metastasis; 1993 Nov; 11(6):453-61. PubMed ID: 7900945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells.
    De Corte V; De Potter C; Vandenberghe D; Van Laerebeke N; Azam M; Roels H; Mareel M; Vandekerckhove J
    J Cell Sci; 1994 Mar; 107 ( Pt 3)():405-16. PubMed ID: 7911804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.
    Lupu R; Colomer R; Zugmaier G; Sarup J; Shepard M; Slamon D; Lippman ME
    Science; 1990 Sep; 249(4976):1552-5. PubMed ID: 2218496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte induced chemotaxis in the pathogenesis of Paget's disease of the breast.
    de Potter CR; Eeckhout I; Schelfhout AM; Geerts ML; Roels HJ
    Histopathology; 1994 Apr; 24(4):349-56. PubMed ID: 7519165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease.
    Costa MJ; Walls J; Trelford JD
    Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-erbB-3 protein expression in ductal carcinoma in situ of the breast.
    Bobrow LG; Millis RR; Happerfield LC; Gullick WJ
    Eur J Cancer; 1997 Oct; 33(11):1846-50. PubMed ID: 9470844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays.
    Beckmann MW; Toney LJ; Scharl A; Fuchs-Young R; Greene GL; Holt JA
    Eur J Cancer; 1992; 28(2-3):322-6. PubMed ID: 1350453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
    Kameda T; Yasui W; Yoshida K; Tsujino T; Nakayama H; Ito M; Ito H; Tahara E
    Cancer Res; 1990 Dec; 50(24):8002-9. PubMed ID: 1979253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity.
    An WG; Schnur RC; Neckers L; Blagosklonny MV
    Cancer Chemother Pharmacol; 1997; 40(1):60-4. PubMed ID: 9137531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family.
    Schelfhout VR; Coene ED; Delaey B; Thys S; Page DL; De Potter CR
    J Natl Cancer Inst; 2000 Apr; 92(8):622-8. PubMed ID: 10772679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Exp Cell Res; 1997 Mar; 231(2):251-9. PubMed ID: 9087165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neu-oncogene: more than a prognostic indicator?
    De Potter CR
    Hum Pathol; 1994 Dec; 25(12):1264-8. PubMed ID: 8001919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance.
    Blin N; Kardaś I; Welter C; Ryś J; Niezabitowski A; Limon J; Seitz G
    Oncology; 1993; 50(6):408-11. PubMed ID: 7901823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of heregulin, a specific activator of p185erbB2.
    Holmes WE; Sliwkowski MX; Akita RW; Henzel WJ; Lee J; Park JW; Yansura D; Abadi N; Raab H; Lewis GD
    Science; 1992 May; 256(5060):1205-10. PubMed ID: 1350381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The subcellular localization of the neu protein in human normal and neoplastic cells.
    De Potter CR; Quatacker J; Maertens G; Van Daele S; Pauwels C; Verhofstede C; Eechaute W; Roels H
    Int J Cancer; 1989 Dec; 44(6):969-74. PubMed ID: 2575084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin MUC1 is seen in cell surface protrusions together with ezrin in immunoelectron tomography and is concentrated at tips of filopodial protrusions in MCF-7 breast carcinoma cells.
    Bennett R; Järvelä T; Engelhardt P; Kostamovaara L; Sparks P; Carpén O; Turunen O; Vaheri A
    J Histochem Cytochem; 2001 Jan; 49(1):67-77. PubMed ID: 11118479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective counterstaining of the plasma membrane improves the immunoelectron microscopic detection of neu protein at the cell border.
    Quatacker J; De Potter C; Van Daele S; Roels H
    Acta Histochem Suppl; 1990; 40():105-7. PubMed ID: 1982565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and biological activities of monoclonal antibody against p185erbB2].
    Han M; Jiang B; Wu J; Shou C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 35(2):154-8. PubMed ID: 12920832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity.
    Matsuda S; Kawamura-Tsuzuku J; Ohsugi M; Yoshida M; Emi M; Nakamura Y; Onda M; Yoshida Y; Nishiyama A; Yamamoto T
    Oncogene; 1996 Feb; 12(4):705-13. PubMed ID: 8632892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.
    Alper O; Yamaguchi K; Hitomi J; Honda S; Matsushima T; Abe K
    Cell Growth Differ; 1990 Dec; 1(12):591-9. PubMed ID: 1981143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.